A detailed history of Morgan Stanley transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 472 shares of ETON stock, worth $5,933. This represents 0.0% of its overall portfolio holdings.

Number of Shares
472
Previous 192 145.83%
Holding current value
$5,933
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.28 - $6.0 $918 - $1,680
280 Added 145.83%
472 $2,000
Q2 2024

Oct 17, 2024

BUY
$3.06 - $3.75 $471 - $577
154 Added 405.26%
192 $0
Q2 2024

Aug 14, 2024

BUY
$3.06 - $3.75 $471 - $577
154 Added 405.26%
192 $0
Q1 2024

Oct 17, 2024

SELL
$3.48 - $5.03 $535 - $774
-154 Reduced 80.21%
38 $0
Q4 2023

Aug 16, 2024

SELL
$3.45 - $4.66 $531 - $717
-154 Reduced 80.21%
38 $0
Q4 2023

Feb 13, 2024

SELL
$3.45 - $4.66 $200 - $270
-58 Reduced 60.42%
38 $0
Q3 2023

Nov 15, 2023

SELL
$2.55 - $5.63 $1,907 - $4,211
-748 Reduced 88.63%
96 $0
Q2 2023

Aug 14, 2023

SELL
$3.32 - $4.04 $6,175 - $7,514
-1,860 Reduced 68.79%
844 $2,000
Q1 2023

May 15, 2023

SELL
$2.89 - $4.1 $15,712 - $22,291
-5,437 Reduced 66.79%
2,704 $10,000
Q4 2022

Feb 14, 2023

BUY
$2.02 - $3.25 $2,809 - $4,520
1,391 Added 20.61%
8,141 $22,000
Q3 2022

Nov 14, 2022

SELL
$2.04 - $3.03 $3,437 - $5,105
-1,685 Reduced 19.98%
6,750 $14,000
Q2 2022

Oct 27, 2022

SELL
$2.55 - $4.38 $50,071 - $86,005
-19,636 Reduced 69.95%
8,435 $23,000
Q2 2022

Aug 15, 2022

SELL
$2.55 - $4.38 $50,071 - $86,005
-19,636 Reduced 69.95%
8,435 $23,000
Q1 2022

Oct 27, 2022

BUY
$3.43 - $4.69 $67,351 - $92,092
19,636 Added 232.79%
28,071 $122,000
Q1 2022

May 13, 2022

SELL
$3.43 - $4.69 $6,863 - $9,384
-2,001 Reduced 6.65%
28,071 $122,000
Q4 2021

Feb 14, 2022

SELL
$3.66 - $6.59 $17,117 - $30,821
-4,677 Reduced 13.46%
30,072 $129,000
Q3 2021

Nov 15, 2021

BUY
$4.2 - $6.26 $145,945 - $217,528
34,749 New
34,749 $175,000

Others Institutions Holding ETON

About Eton Pharmaceuticals, Inc.


  • Ticker ETON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,297,000
  • Market Cap $318M
  • Description
  • Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...
More about ETON
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.